From the journal:

Chemical Communications

Retraction: A robust collagen-targeting MRI peptide contrast agent for in vivo imaging of hepatic fibrosis

Zhao Liu,ab   Linge Nian,a   Xiangdong Cai,a   Yue Hu,a   Junqiang Lei*b  and  Jianxi Xiao*a  

* Corresponding authors

a State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, P. R. China
E-mail: xiaojx@lzu.edu.cn

b The First Hospital of Lanzhou University, Lanzhou, P. R. China
E-mail: leijq1990@163.com

Abstract

Retraction of ‘A robust collagen-targeting MRI peptide contrast agent for in vivo imaging of hepatic fibrosis’ by Zhao Liu et al., Chem. Commun., 2023, 59, 6068–6071, https://doi.org/10.1039/D3CC01096A.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D4CC90264E
Article type
Retraction
Submitted
29 Jul 2024
Accepted
29 Jul 2024
First published
27 Sep 2024
This article is Open Access
Creative Commons BY license

Chem. Commun., 2024, Advance Article

Permissions

Request permissions

Retraction: A robust collagen-targeting MRI peptide contrast agent for in vivo imaging of hepatic fibrosis

Z. Liu, L. Nian, X. Cai, Y. Hu, J. Lei and J. Xiao, Chem. Commun., 2024, Advance Article , DOI: 10.1039/D4CC90264E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements